Compared with placebo, viscosupplementation provided a small reduction in pain but increased risk of serious adverse events in patients with knee osteoarthritis, according to published results ...

The FDA approved viscosupplementation for osteoarthritis of the knee in 1997. There are several products on the market, one of which is a natural product made from the comb of a rooster.

Source Reference: Pereira T, et al "Viscosupplementation for knee osteoarthritis: systematic review and meta-analysis" BMJ 2022; DOI: 10.1136/bmj-2022-069722. Share on Facebook. Opens in a new tab ...

DUBLIN--(BUSINESS WIRE)--The "Global Hyaluronic Acid Viscosupplementation Market Size, Share, and COVID-19 Impact Analysis 2023-2029 MedCore - Includes: Single Injection, Two Injections, and 2 ...

Shear-Thinning Biomaterial for Embolic Applications: Interview with Upma Sharma, President and CEO of Arsenal Medical ...